BETA TRUTIDE -The Next-Gen Triagonist for Obesity, Diabetes & Liver Health
BETA TRUTIDE is an investigational triple hormone receptor agonist for obesity, diabetes, and NASH, targeting GLP-1, GIP, and glucagon receptors.
- The description claims BETA TRUTIDE demonstrates robust weight loss and enhanced glycemic regulation.
Variants (1)
- Default Title — 25000.00 INR — In stock
AI Readiness
Good foundation, but some important product data is still missing.
72%